Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

 50.27 51.33 41.01 36.74
P/S ratio 12.28 12.64 10.07 9.13
P/FCF ratio 59.28 56.88 42.30 33.60
P/Operating CF 127.19 152.94 168.09 119.73
P/B ratio 32.78 33.89 28.76 25.78
Price to Tangible BV 49.55 50.31 43.06 37.67
EV/Sales 12.36 12.71 10.12 9.18
EV/EBITDA 35.60 36.33 28.94 25.93
EV/Operating CF 47.32 46.27 37.19 30.49
EV/FCF 59.65 57.16 42.53 33.80
Quick Ratio 0.62 0.64 0.62 0.64
Current Ratio 1.18 1.23 1.12 1.17
Net Debt/EBITDA 0.81 0.76 0.62 0.54
Debt/Assets 15.50% 13.42% 13.29% 13.07%
Debt/Equity 0.34 0.28 0.29 0.28
Asset Turnover 1.24 1.30 1.35 1.34
Operating CF/Net income 1.47 1.43 0.96 1.03
Capex/Depreciation (1.21) (0.77) (0.90) (0.65)
Interest Coverage 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 5.74% 6.13% 5.77% 5.38%
Selling, General and Administrative Expense of Revenue 23.99% 25.28% 25.80% 23.68%
Intangible Assets out of Total Assets 0.16 0.16 0.15 0.15
Share Based Compensation of Revenue 1.31% 1.48% 1.43% 1.32%
Graham Net Nets (0.01) (0.01) (0.01) (0.01)
Graham Number 74.66 76.94 77.60 81.15
Earnings Yield 1.99% 1.95% 2.44% 2.72%
Free Cash Flow Yield 1.69% 1.76% 2.36% 2.98%
Revenue per Share 13.80 13.56 14.32 15.41
Operating CF per Share 5.02 4.42 3.34 4.40
Capex per Share (0.56) (0.37) (0.42) (0.34)
Free Cash Flow per Share 4.47 4.05 2.92 4.06
Cash per Share 2.60 2.24 2.52 2.49
Shareholders Equity per Share 19.49 19.96 19.54 20.42
Interest Debt per Share 0.00 0.00 0.00 0.00
Book value per Share 19.49 19.96 19.54 20.42
Free Cash Flow 357.88 326.13 232.46 320.62
Working Capital 225.24 265.01 154.22 221.82
Capital Expenditures (44.46) (29.63) (33.78) (26.54)
Net Current Asset Value (348.47) (331.55) (375.32) (320.27)
EV/EBIT 39.42 40.21 32.01 28.67
Capex to Sales 0.04 0.03 0.03 0.02
Net Profit Margin 24.85% 22.76% 24.41% 27.82%
Price to Operating Income 39.18 40.01 31.83 28.50
Other line items
Average Receivables 539.07 512.98 565.50 593.82
Average Payables 116.43 112.31 125.04 122.84
Average Inventory 390.68 379.82 389.19 392.08
Average Assets 3,368.74 3,322.10 3,299.59 3,386.56
Average Common Equity 1,589.62 1,600.35 1,502.06 1,535.70

Fold the line items

Columns are period end dates